A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives. For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how members of the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.
A gripping business narrative and scientific thriller about what it takes to bring a wonder drug to market—and save countless lives. For Blood and Money tells the little-known story of how an upstart biotechnology company created a one-in-a-million cancer drug, and how members of the core team—denied their share of the profits—went and did it again. In this epic saga of money and science, veteran financial journalist Nathan Vardi explains how the invention of two of the biggest cancer drugs in history became (for their backers) two of the greatest Wall Street bets of all time. In the multibillion-dollar business of biotech, where pharmaceutical companies, the government, hedge funds, and venture capitalists have spent billions on funding, experimentation, and treatments, a single molecule can stop cancer in its tracks—and make the people who find that rare molecule astonishingly rich. For Blood and Money follows a small team at a biotech start-up in California, who have found one of these rare molecules. Their compound, known as a BTK inhibitor, seems to work on a vicious type of leukemia. When patients start rising from their hospice beds, the team knows they’re onto something big. What follows is a story of genius, pathos, and drama, in which vivid characters navigate a world of corporate intrigue and ambiguous morality. Vardi’s narrative immerses readers in the recent explosion of biotech start-ups. He describes the scientists, doctors, and investors who are risking everything to develop new, life-saving treatments, and introduces suffering patients for whom the stakes are life-or-death. A gripping nonfiction read, For Blood and Money illustrates why it’s so hard to bring new drugs to market, explains why they are so expensive, and examines how profit-driven venture capitalists are shaping the future of medicine.
Rich in human experience and historic detail, these fascinating accounts portray the activities of Jewish scholars, merchants, pilgrims, ambassadors, and other wanderers. Nineteen engaging narratives, some of them 12 centuries old, offer rare perspectives on the unfolding drama of life in medieval Europe, the Near East, and Africa.
Women were involved in every popular philosophy in the first century, and the participation of women reaches back to the Greek origins of these schools. Philosophers often taught their daughters, wives, and other friends the basic tenets of their thinking. The Isthmian games and a tolerance for independent thinking made Corinth an attractive place for philosophers to engage in dialogue and debate, further facilitating the philosophical education of women. The activity of philosophically educated women directly informs our understanding of 1 Corinthians when Paul uses concepts that also appear in popular moral philosophy. This book explores how philosophically educated women would interact with three such concepts: marriage and family, patronage, and self-sufficiency.
As significant economic, social, political, and cultural transformations swept the Jewish population of Tsarist Russia and Congress Poland between 1860 and 1914, the Yiddish language (Zhargon) began to gain recognition as a central part of the Jewish cultural stage. Yiddish Transformed examines the secular reading habits of East-European Jews as the Jewish community began shifting to a modern society. Author Nathan Cohen explores Jewish reading practices alongside the rise of Yiddish by delving into publishing policies of Yiddish books and newspapers, popular literary genres of the time, the development of Jewish public libraries, as well as personal reflections of reading experiences.
Do you want your students to engage with and retain psychology’s key principles, and to work toward becoming better students and better people in the process? Best-selling Exploring Psychology offers creative ways to help make it happen. The new edition of Exploring Psychology offers outstanding currency on the research, practice, and teaching of psychology. Myers and DeWall inspire students with fascinating findings and applications, effective new study tools and technologies, and a compassionate and compelling storytelling voice. Their presentation is based on the same guiding principles that made David Myers the world’s bestselling introductory psychology author. Facilitate learning by teaching critical thinking and helping students at every step. Present psychology as a science, emphasizing the process of inquiry and putting facts in the service of concepts. Make sure students come away with an appreciation of psychology's big ideas, and with a deeper respect for humanity--what drives us, distinguishes us, unifies us.
An up-to-date clinically focused text written to answer even the most difficult obstetrics and gynecology question A Doody’s Core Title for 2021! The single-source OB/GYN resource acclaimed for its currency, comprehensiveness, and strong focus on the practical aspects of clinical diagnosis and patient management Expanded and extensively updated to reflect the latest research and advances – including the concepts of precision medicine Of value to medical students, residents, and practicing physicians who will find this an outstanding guide to the management of common and uncommon conditions Ready-to-apply coverage of more than 1,000 diseases and disorders Strikes the perfect balance between brevity and clinical necessity, delivering exactly the amount of information needed for quick diagnosis, effective treatment, and improved outcomes Strong emphasis on disease prevention and evidence-based medicine Hundreds anatomic drawings, image studies, diagrams, charts, and graphs NEW CHAPTER on Benign Disorders of the Uterine Corpus; Cardiac Disorders in Pregnancy and Pulmonary Disorders in Pregnancy are now two separate chapters for more detailed, focused coverage of these important topics Quick-access design facilities use at the point of care
Practical, up-to-date, and ready-to-apply coverage of more than 1,000 diseases and disorders CURRENT Diagnosis & Treatment Obstetrics & Gynecology, 11e is a concise, yet comprehensive textbook on the medical and surgical management of obstetrics and gynecology. It succinctly covers more than 1,000 diseases and disorders,the latest screening guidelines, and underlying pathophysiology when relevant. The eleventh edition is enriched by contributions from more than 85 world-renowned contributors Thoroughly reviews all of obstetrics and gynecology Focuses on the practical aspects of clinical diagnosis and patient management Covers pathophysiology when relevant to diagnosis and treatment Emphasizes disease prevention and evidence-based medicine Includes more than 500 anatomic drawings, image studies, and diagrams Completely updated to reflect the latest research and advances Consistent presentation includes Clinical Findings, Diagnosis, Treatment, and Complications and Prognosis Quick-access design facilitates use at the point of care Updated to include the latest screening and management guidelines
Practical, up-to-date, and ready-to-apply coverage of more than 1,000 diseases and disorders For more than 70 years, professors, students, and clinicians have trusted LANGE for high-quality, current, concise medical information in a convenient, affordable, portable format. Whether for coursework, clerkships, USMLE prep, specialty board review, or patient care, there's a LANGE book that guarantees success. CURRENT Diagnosis & Treatment Obstetrics & Gynecology, 11e is a concise, yet comprehensive textbook on the medical and surgical management of obstetrics and gynecology. It succinctly covers more than 1,000 diseases and disorders,the latest screening guidelines, and underlying pathophysiology when relevant. The eleventh edition is enriched by contributions from more than 85 world-renowned contributors Thoroughly reviews all of obstetrics and gynecology Focuses on the practical aspects of clinical diagnosis and patient management Covers pathophysiology when relevant to diagnosis and treatment Emphasizes disease prevention and evidence-based medicine Includes more than 500 anatomic drawings, image studies, and diagrams Completely updated to reflect the latest research and advances Consistent presentation includes Clinical Findings, Diagnosis, Treatment, and Complications and Prognosis Quick-access design facilitates use at the point of care Updated to include the latest screening and management guidelines
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.